Efficacy and Safety of High-Dose TBS on Poststroke Upper Extremity Motor Impairment: A Randomized Controlled Trial

被引:3
|
作者
Tang, Zhiqing [1 ,7 ]
Huang, Jianting [2 ,3 ,5 ]
Zhou, Ying [2 ]
Ren, Jianxun [2 ]
Duan, Xinyu [2 ]
Fu, Xiaoxuan [2 ]
Pan, Ruiqi [6 ]
Wang, Rongrong [1 ,7 ]
Zhang, Ping [2 ]
Ding, Mengying [6 ]
Sun, Jian [6 ]
Zhang, Xiaonian [1 ,7 ]
Chi, Qianqian [1 ,7 ]
Zhang, Yue [1 ,7 ]
Zhang, Xin [1 ,7 ]
Yu, Weiyong [1 ,8 ]
Xu, Liu [9 ]
Zhang, Hao [1 ,7 ,10 ,11 ]
Liu, Hesheng [2 ,4 ]
机构
[1] Capital Med Univ, Sch Rehabil, 10 Xitoutiao, Beijing, Peoples R China
[2] Changping Lab, Beijing, Peoples R China
[3] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China
[4] Peking Univ, Biomed Pioneering Innovat Ctr, 5 Yiheyuan Rd, Beijing 100871, Peoples R China
[5] Chinese Inst Brain Res, Beijing, Peoples R China
[6] Neural Galaxy Inc, Beijing, Peoples R China
[7] Beijing Boai Hosp, China Rehabil Res Ctr, Dept Neurorehabil, Beijing, Peoples R China
[8] Beijing Boai Hosp, China Rehabil Res Ctr, Dept Radiol, Beijing, Peoples R China
[9] Sichuan Univ, West China Med Sch, Chengdu, Peoples R China
[10] Univ Hlth & Rehabil Sci, Qingdao, Peoples R China
[11] Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R China
基金
中国博士后科学基金;
关键词
magnetic resonance imaging; neurological rehabilitation; stroke; transcranial magnetic stimulation; upper extremity; TRANSCRANIAL MAGNETIC STIMULATION; NONINVASIVE BRAIN-STIMULATION; THETA-BURST STIMULATION; UPPER-LIMB; STROKE; RECOVERY; CORTEX; CONNECTIVITY; IMPROVEMENT; NETWORKS;
D O I
10.1161/STROKEAHA.124.046597
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND:Upper extremity (UE) motor function impairment is a major poststroke complication whose recovery remains one of the most challenging tasks in neurological rehabilitation. This study examined the efficacy and safety of the personalized neuroimaging-guided high-dose theta-burst stimulation (TBS) for poststroke UE motor function recovery.METHODS:Patients after stroke with UE motor impairment from a China rehabilitation center were randomly assigned to receive high-dose intermittent TBS (iTBS) to ipsilesional UE sensorimotor network, continuous TBS (cTBS) to contralesional UE sensorimotor network, or sham stimulation, along with conventional therapy for 3 weeks. The primary outcome was the score changes on the Fugl-Meyer assessment-UE from baseline to 1 and 3 weeks. The secondary outcomes included the response rate on Fugl-Meyer assessment-UE scores posttreatment (>= 9-point improvement) and score changes in multidimensional scales measuring UE, lower extremity, and activities and participation.RESULTS:From June 2021 to June 2022, 45 participants were randomized and 43 were analyzed. The iTBS and continuous TBS groups showed significantly greater improvement in Fugl-Meyer assessment-UE (mean improvement, iTBS: 10.73 points; continuous TBS: 10.79 points) than the sham group (2.43 points) and exhibited significantly greater response rates on Fugl-Meyer assessment-UE (iTBS, 60.0%; continuous TBS, 64.3%) than the sham group (0.0%). The active groups consistently exhibited superior improvement on the other 2 UE assessments at week 3. However, only the iTBS group showed greater efficacy on 1 lower extremity assessment than the sham group at week 3. Both active groups showed significant improvements in activities and participation assessments.CONCLUSIONS:The study provides evidence for the efficacy and safety of high-dose TBS in facilitating poststroke UE rehabilitation.REGISTRATION:URL: www.chictr.org.cn; Unique identifier: ChiCTR2100047340.
引用
收藏
页码:2212 / 2220
页数:9
相关论文
共 50 条
  • [1] Efficacy and safety of high-dose and personalized TBS on post-stroke cognitive impairment: A randomized controlled trial
    Ren, Jianxun
    Su, Wenlong
    Zhou, Ying
    Han, Kaiyue
    Pan, Ruiqi
    Duan, Xinyu
    Liu, Jiajie
    Lu, Haitao
    Zhang, Ping
    Zhang, Wei
    Sun, Jian
    Ding, Mengying
    Zhu, Yafei
    Xie, Wuxiang
    Huang, Jianting
    Zhang, Hao
    Liu, Hesheng
    BRAIN STIMULATION, 2025, 18 (02) : 249 - 258
  • [2] Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis A Randomized Controlled Trial
    Velasquez, Gustavo E.
    Brooks, Meredith B.
    Coit, Julia M.
    Pertinez, Henry
    Vargas Vasquez, Dante
    Sanchez Garavito, Epifanio
    Calderon, Roger I.
    Jimenez, Judith
    Tintaya, Karen
    Peloquin, Charles A.
    Osso, Elna
    Tierney, Dylan B.
    Seung, Kwonjune J.
    Lecca, Leonid
    Davies, Geraint R.
    Mitnick, Carole D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (05) : 657 - 666
  • [3] Efficacy of Upper Extremity Robotic Therapy in Subacute Poststroke Hemiplegia An Exploratory Randomized Trial
    Takahashi, Kayoko
    Domen, Kazuhisa
    Sakamoto, Tomosaburo
    Toshima, Masahiko
    Otaka, Yohei
    Seto, Makiko
    Irie, Katsumi
    Haga, Bin
    Takebayashi, Takashi
    Hachisuka, Kenji
    STROKE, 2016, 47 (05) : 1385 - 1388
  • [4] Effect of segmental muscle vibration on upper extremity functional ability poststroke A randomized controlled trial
    Annino, Giuseppe
    Alashram, Anas R.
    Alghwiri, Alia A.
    Romagnoli, Cristian
    Messina, Giuseppe
    Tancredi, Virginia
    Padua, Elvira
    Mercuri, Nicola Biagio
    MEDICINE, 2019, 98 (07)
  • [5] Safety of High-Dose Vitamin D Supplementation: Secondary Analysis of a Randomized Controlled Trial
    Billington, Emma O.
    Burt, Lauren A.
    Rose, Marianne S.
    Davison, Erin M.
    Gaudet, Sharon
    Kan, Michelle
    Boyd, Steven K.
    Hanley, David A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04): : 1261 - 1273
  • [6] Robot-Assisted Reach Training With an Active Assistant Protocol for Long-Term Upper Extremity Impairment Poststroke: A Randomized Controlled Trial
    Cho, Ki Hun
    Song, Won-Kyung
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2019, 100 (02): : 213 - 219
  • [7] Re: Safety of High-Dose Vitamin D Supplementation: Secondary Analysis of a Randomized Controlled Trial
    Assimos, Dean G.
    JOURNAL OF UROLOGY, 2020, 203 (06): : 1056 - 1056
  • [8] Comparing efficacy and safety of high-dose and standard-dose rifampicin in the treatment of brucellosis: a randomized clinical trial
    Salehi, Mohammadreza
    Farbod, Farnaz
    Khalili, Hossein
    Rahmani, Hamid
    Jafari, Sirous
    Abbasi, Ali
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (04) : 1084 - 1091
  • [9] High-dose cephalexin for cellulitis: a pilot randomized controlled trial
    Yadav, Krishan
    Eagles, Debra
    Perry, Jeffrey J.
    Taljaard, Monica
    Sandino-Gold, Gabriel
    Nemnom, Marie-Joe
    Corrales-Medina, Vicente
    Suh, Kathryn N.
    Stiell, Ian G.
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2023, 25 (1) : 22 - 30
  • [10] A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias
    Gilron, I
    Booher, SL
    Rowan, JS
    Smoller, B
    Max, MB
    NEUROLOGY, 2000, 55 (07) : 964 - 971